Yazar "Kuku, Irfan" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    Fulminant progression of peripheral T-cell lymphoma with skin involvement mimicking zona zoster: Letter to editor
    (2012) Demircioglu, Sinan; Aydogdu, Ismet; Erkurt, Mehmet Ali; Gurses, Iclal; Kuku, Irfan; Kaya, Emin; Ozhan, Onur
    Burada periferik T hücreli lenfomalı bir erkek hasta sunduk. Hasta remisyona girdikten iki ay sonra nüks etti. Kurtarma tedavisi sırasında vefat etti. Periferik T hücreli lenfomalar kötü prognoza sahiptir ve agresif seyir gösterirler. Hastalar hızlı değerlendirilmelidir. Çünkü kemoterapinin başarı şansı düşüktür. Tedavi için kemik iliği nakli akılda tutulmalıdır.
  • Küçük Resim Yok
    Öğe
    The levels of nitric oxide in megaloblastic anemia
    (AVES YAYINCILIK, 2009) Erkurt, Mehmet Ali; Aydogdu, Ismet; Bayraktar, Nihayet; Kuku, Irfan; Kaya, Emin
    Objective: The purpose of this study was to investigate the relationship between nitric oxide degradation products (nitrate and nitrite) levels and megaloblastic anemia which is treated with cyalocobalamin. Materials and Methods: A total of 30 patients with megaloblastic anemia (16 Male, 14 Female) were included in the study, Cyanocobalamin was administered (1.000 mu g/day intramuscularly) until the reticulocyte crisis occurred to the normal range. The control group consisted of 30 healthy subjects (15 Male, 15 Female). Nitric oxide levels were measured before treatment and compared with the values obtained during peak reticulocyte count. Results: Plasma direct nitrite, total nitrite and nitrate levels were 24,86 +/- 3,87, 60.56 +/- 7,01 and 36,02 +/- 5,24 in before treatment versus 15,48 +/- 3,05, 38,92 +/- 6,44 and 22,77 +/- 6,04 mu mol/dl in after treatment, respectively, Plasma direct nitrite, total nitrite and nitrate levels were significantly lower in after treatment compared with the before treatment (p<0.001). Conclusion: Nitric oxide levels are seen to increase in megaloblastic anemia. This study suggested that abnormalities in the nitric oxide levels in megaloblastic anemia are restored by vitamin B12 replacement therapy. (Turk J Hematol 2009; 26: 197-200)